Kane Biotech launches 2021 business update series
16 juin 2021 10h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 16, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), goes live today with the first of a 5-part “2021 business update”...
Kane Biotech Announces Adoption of Performance and Restricted Share Unit Plan and Amended and Restated Stock Option Plan
09 juin 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, June 09, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF), (the “Company” or “Kane Biotech”), today announced that, at the annual and special meeting of...
Kane Biotech Announces First Quarter 2021 Financial Results
27 mai 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 27, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), today announced first quarter 2021 financial results. First...
Kane Biotech to Release First Quarter 2021 Financial Results on May 27 – Conference Call to Follow
20 mai 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, May 20, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech Announces Strong Positive Results of DermaKB™ Shampoo Consumer Trial
29 avr. 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 29, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), is pleased to announce that it has published strong positive...
Kane Biotech Strengthens Board with Biotech Executive
13 avr. 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, April 13, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), is pleased to announce that Dr. Allan Mandelzys has been engaged...
Kane Biotech Announces Fourth Quarter and Full Year 2020 Financial Results
25 mars 2021 16h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 25, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech to Release Fourth Quarter and Full Year 2020 Financial Results on March 25 – Conference Call to Follow
18 mars 2021 16h30 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 18, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and...
Kane Biotech to Participate in Maxim Group LLC Inaugural Emerging Growth Conference
11 mars 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 11, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that Marc Edwards, CEO will be presenting at the...
Kane Biotech Announces Positive Efficacy Results in STEM Pet Oral Care Clinical Trial
10 mars 2021 08h00 HE
|
Kane Biotech Inc.
WINNIPEG, Manitoba, March 10, 2021 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane”), announced today that preliminary analysis of data from efficacy trials...